Skip to navigation Skip to content



Congress passes short-term funding bill through December 2022 

September 30, 2022

Today, Congress passed a continuing resolution (CR) to fund the government for the beginning of fiscal year 2023. This resolution is a short-term funding bill set to expire on December 16, 2022.  This legislation keeps spending at the same levels set for last year and gives the appropriations committees in the House and Senate more time to finalize spending for the rest of fiscal year 2023.   

In addition to level funding, the continuing resolution included:  
  • $12 billion in funding for Ukraine assistance, as well as under 3 billion in natural disaster recovery assistance and low-income home heating aid.  
  • Language reauthorizing the Food and Drug Administration (FDA) user fee program for another five years which will avert any delays in the review of new drugs.  
Additional funding for vaccines, testing and treatment for COVID or monkey-pox-- which was requested by the White House-- was not included.   

The House and Senate will now have until December 16th to pass legislation to fund the government for the rest of  fiscal year 2023—including increased investments in Society priorities such as medical research. If they do not pass a new package, Congress will need to pass an additional short-term funding extension or face a government shutdown. 

Learn more about the National MS Society's policy priorities.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. Symptoms range from numbness and tingling to blindness and paralysis, and there is currently no cure for MS. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. An estimated 1 million people live with MS in the United States. Most people with MS are diagnosed between the ages of 20 and 50, and it affects women three times more than men.


© 2023 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.